Section 6: Education and Research

6ER-015

IMPACT ON PAIN MANAGEMENT AFTER A SINGLE VISCOSUPPLEMENTATION INTRAARTICULAR INJECTION IN PATIENTS WITH HIP OSTEOARTHRITIS WHO FAILED CONVENTIONAL TREATMENT

6ER-014

PLATELET-RICH PLASMA: WHAT ARE WE REALLY ADMINISTERING TO OUR PATIENTS?

6ER-013

A PILOT RANDOMISED DOUBLE-BLINDED PLACEBO-CONTROLLED TRIAL OF PROPHYLACTIC SILDENAFIL IN PRETERM INFANTS AT RISK OF BRONCHOPULMONARY DYSPLASIA

6ER-012

EFFICACY AND SAFETY ANALYSIS OF ALEMTUZUMAB IN RELAPSING-REMITTING MULTIPLE SCLEROSIS

6ER-011

MODELLING THE IMPACT OF DISCOUNTS ON THE REAL-LIFE COST-EFFECTIVENESS OF BIOLOGIC THERAPIES IN THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS IN SPAIN

6ER-010

PUBLIC KNOWLEDGE AND PERCEPTION TOWARDS VACCINES IN ITALY

6ER-009

PATIENT SATISFACTION AND KNOWLEDGE AFTER SWITCHING FROM EVIPLERA TO ODEFSEY

6ER-008

PERSISTENCE AND REASONS FOR SWITCHING THE INITIAL ANTIRETROVIRAL TREATMENT IN A COHORT OF NAÏVE HIV-INFECTED PATIENTS

6ER-007

OFF-LABEL USE OF DALBAVANCIN IN GRAM-POSITIVE INFECTIONS: EFFECTIVENESS, SAFETY AND COST IN CLINICAL PRACTICE

6ER-006

EFFECTS OF STATINS USE ON CLINICAL OUTCOMES IN PATIENTS ADMITTED WITH COMMUNITY-ACQUIRED PNEUMONIA

6ER-005

USE OF SACUBITRIL/VALSARTAN IN PATIENTS WITH CHRONIC HEART FAILURE

6ER-003

COST OF VENOUS THROMBOEMBOLIC DISEASE IN PATIENTS WITH LUNG AND PROSTATE CANCE: COSTECAT STUDY

6ER-002

EFFICACY OF A FIXED-RATIO COMBINATION OF INSULIN DEGLUDEC AND LIRAGLUTIDE IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS

6ER-001

HIGH VERSUS LOW DOSE OF URSODEOXYCHOLIC ACID FOR THE MANAGEMENT OF INTRAHEPATIC CHOLESTASIS OF PREGNANCY: A COHORT RETROSPECTIVE STUDY OF MATERNAL AND NEONATAL OUTCOMES

6ER-008

EVALUATION OF PATIENT, VIRUS AND TREATMENT BASELINE FACTORS AFFECTING THE EFFECTIVENESS OF DIRECT ANTIVIRAL AGENTS AGAINST THE HEPATITIS C VIRUS

Pages